Heterogeneity of Low-Density Lipoprotein Particle Number at Normal Concentrations of Lipoprotein (a) in Hyperlipidemia Patients

Lipoprotein (a) [Lp(a)] is used commercially as a marker to predict cardiovascular disease. The clinical utility of routine measurement of Lp(a) is unclear. Furthermore, limited data are available that can be used to evaluate the relationship between low-density lipoprotein particle number (LDL-P) and Lp(a) concentration.